OpenEvidence vs VisualDx:Which is more popular?
In September 2026, OpenEvidence had more branded searches than VisualDx among clinical decision support platforms worldwide. OpenEvidence had about 1.8 million branded searches, while VisualDx had 12,100. OpenEvidence made up 51.5% of all clinical decision support platform searches we track, and VisualDx accounted for 0.34%. When we asked ChatGPT and Google AI Overviews about clinical decision support platforms, OpenEvidence and VisualDx each appeared in two of the five answers. VisualDx was mentioned before OpenEvidence in two out of three answers.
Who do people search for more?
OpenEvidence, about 151 searches for every 1 for VisualDx
Who does AI mention more?
Both were mentioned in 2 of 5 answers.
Who does AI recommend more?
VisualDx, named ahead of OpenEvidence in 2 of 3 answers
Follow OpenEvidence vs VisualDx and get free monthly updates on what changed
By continuing you'll get index updates and occasional product news from Brandwave. Unsubscribe any time. Privacy
Top clinical decision support platforms in ChatGPT and Google AI Overviews
In three ChatGPT questions and two Google AI Overviews, OpenEvidence and VisualDx were each mentioned in two out of five: in two of the three ChatGPT answers, but not in either of the two Google AI Overviews. VisualDx was listed before OpenEvidence in two out of three answers.
Most recommended by AI
Brands get a higher ranking if they are mentioned earlier in the answers.
UpToDate1st
DynaMed2nd- VisualDx3rd
- OpenEvidence4th
BMJ Best Practice5th
Wolters Kluwer6th
Elsevier–
Isabel–
Mentioned by AI
Each dot is one answer, filled in when that answer mentions the brand.
- UpToDate4 of 5Named in 3 of 3 ChatGPT answersNamed in 1 of 2 Google answers
- Wolters Kluwer3 of 5Named in 2 of 3 ChatGPT answersNamed in 1 of 2 Google answers
- DynaMed3 of 5Named in 3 of 3 ChatGPT answersNamed in 0 of 2 Google answers
- OpenEvidence2 of 5Named in 2 of 3 ChatGPT answersNamed in 0 of 2 Google answers
- VisualDx2 of 5Named in 2 of 3 ChatGPT answersNamed in 0 of 2 Google answers
- Elsevier1 of 5Named in 0 of 3 ChatGPT answersNamed in 1 of 2 Google answers
- BMJ Best Practice1 of 5Named in 1 of 3 ChatGPT answersNamed in 0 of 2 Google answers
- Isabel0 of 5Named in 0 of 3 ChatGPT answersNamed in 0 of 2 Google answers
See every answer about clinical decision support platforms
5 answers
Asked ChatGPT
“Which clinical decision support platform should I use?”
Asked ChatGPT
“What are the best clinical decision support platforms?”
Asked ChatGPT
“What's the best clinical decision support platform for evidence based care?”
Searched Google, AI Overview
“clinical decision support software”
Searched Google, AI Overview
“clinical decision support platforms”
Not named in any answer:
Brands are shown in the order each answer named them. The survey took place in the United States on October 20, 2026.
Is OpenEvidence or VisualDx more popular in search?
This chart shows how often people search Google for OpenEvidence and VisualDx by name. Each line represents a brand's share of searches for all eight clinical decision support platforms we track, month by month, from English-language searches worldwide.
Share of searches by month for OpenEvidence, VisualDx. The figures are in the table below the chart.
View monthly share of searches table
| Month | OpenEvidence | UpToDate | Elsevier | Isabel | Wolters Kluwer | DynaMed | BMJ Best Practice | VisualDx |
|---|---|---|---|---|---|---|---|---|
| Oct 2025 | 38.8% | 38.8% | 11.7% | 4.3% | 4.3% | 1.1% | 0.58% | 0.39% |
| Nov 2025 | 34% | 41.5% | 12.5% | 5.6% | 4.6% | 0.92% | 0.5% | 0.41% |
| Dec 2025 | 37.8% | 37.8% | 11.4% | 6.2% | 5.1% | 0.84% | 0.56% | 0.37% |
| Jan 2026 | 39.1% | 39.1% | 9.6% | 5.3% | 5.3% | 0.87% | 0.47% | 0.32% |
| Feb 2026 | 42% | 34.4% | 10.4% | 4.6% | 6.9% | 0.76% | 0.62% | 0.34% |
| Mar 2026 | 43.3% | 35.3% | 10.6% | 3.9% | 4.8% | 0.78% | 0.96% | 0.35% |
| Apr 2026 | 48.8% | 32.5% | 9.8% | 3.6% | 3.6% | 0.72% | 0.59% | 0.32% |
| May 2026 | 47.6% | 31.7% | 9.6% | 5.2% | 4.3% | 0.7% | 0.57% | 0.31% |
| Jun 2026 | 49.1% | 32.7% | 8% | 4.4% | 4.4% | 0.59% | 0.4% | 0.32% |
| Jul 2026 | 53.5% | 29.3% | 7.2% | 4.8% | 3.9% | 0.53% | 0.35% | 0.35% |
| Aug 2026 | 52.6% | 28.8% | 8.7% | 4.7% | 3.9% | 0.64% | 0.35% | 0.35% |
| Sep 2026 | 51.5% | 28.2% | 10.4% | 4.6% | 3.8% | 0.63% | 0.51% | 0.34% |
How has the OpenEvidence and VisualDx comparison changed over the last 12 months?
3 findings
- OpenEvidence was ahead of VisualDx in every measured month of the 12 months ending September 2026.
- Across the 12 months ending September 2026, OpenEvidence’s share of searches among clinical decision support platforms worldwide moved from 38.8% to 51.5%, and its estimated monthly branded searches moved from 1.2M to 1.8M.
- Across the 12 months ending September 2026, VisualDx’s share of searches among clinical decision support platforms worldwide moved from 0.39% to 0.34%, and its estimated monthly branded searches held steady at 12.1K.
How did search popularity change for clinical decision support platforms worldwide in September 2026?
1 change
In September 2026, OpenEvidence lost share of searches among clinical decision support platforms worldwide, from 52.6% to 51.5%.
How are branded searches counted?
2 search terms
Brandwave collects information about searches that people make online using OpenEvidence’s and VisualDx’s names. When viewed over time, estimated search volumes for these branded terms can be used to understand whether interest in the brands is growing, holding steady, or fading.
OpenEvidence
1 branded search term
- openevidence
VisualDx
1 branded search term
- visualdx
Other head-to-heads among clinical decision support platforms
Put your own brand in this comparison
Brandwave tracks your branded demand next to the rival you actually watch, with your campaigns, spend and outcomes on the same timeline.